Mandel-Brehm et al. reported that ZSCAN1 autoantibodies were detected in patients with tumor-associated ROHHAD syndrome [21]. Here, ZSCAN1 is linked to rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome.